Clinical response to therapy targeted at vascular endothelial growth factor in metastatic renal cell carcinoma: impact of patient characteristics and Von Hippel-Lindau gene status. (Q46014175)

From Wikidata

Jump to navigation Jump to search

scientific article published on 7 July 2006

Language	Label	Description	Also known as
English	Clinical response to therapy targeted at vascular endothelial growth factor in metastatic renal cell carcinoma: impact of patient characteristics and Von Hippel-Lindau gene status.	scientific article published on 7 July 2006

Statements

scholarly article

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/16827904

Clinical response to therapy targeted at vascular endothelial growth factor in metastatic renal cell carcinoma: impact of patient characteristics and Von Hippel-Lindau gene status. (English)

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/16827904

0 references

1 reference

based on heuristic

inferred from title

renal cell carcinoma

1 reference

based on heuristic

inferred from title

metastatic renal cell carcinoma

1 reference

based on heuristic

inferred from title

author name string

Brian I Rini

1

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/16827904

Erich Jaeger

2

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/16827904

Vivian Weinberg

3

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/16827904

Nancy Sein

4

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/16827904

Karen Chew

5

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/16827904

Kristen Fong

6

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/16827904

Jeffery Simko

7

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/16827904

Eric J Small

8

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/16827904

Frederic M Waldman

9

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/16827904

publication date

7 July 2006

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/16827904

BJU International

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/16827904

98

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/16827904

4

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/16827904

756-762

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/16827904

Mutations of the VHL tumour suppressor gene in renal carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06376.X

21 January 2018

Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06376.X

21 January 2018

Hypertension, antihypertensives and mutations in the Von Hippel-Lindau gene in renal cell carcinoma: results from the Netherlands Cohort Study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06376.X

21 January 2018

Prevalence of von Hippel-Lindau gene mutations in sporadic renal cell carcinoma: results from The Netherlands cohort study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06376.X

21 January 2018

Vascular endothelial growth factor expression, angiogenesis, and necrosis in renal cell carcinomas.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06376.X

21 January 2018

Overproduction of vascular endothelial growth factor related to von Hippel-Lindau tumor suppressor gene mutations and hypoxia-inducible factor-1 alpha expression in renal cell carcinomas.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06376.X

21 January 2018

Optimal locoregional treatment in gastric cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06376.X

21 January 2018

A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06376.X

21 January 2018

Cancer and Leukemia Group B 90206: A randomized phase III trial of interferon-alpha or interferon-alpha plus anti-vascular endothelial growth factor antibody (bevacizumab) in metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06376.X

21 January 2018

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06376.X

21 January 2018

Bladder cancer outcome and subtype classification by gene expression

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06376.X

21 January 2018

Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06376.X

21 January 2018

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06376.X

21 January 2018

VHL mutations and their correlation with tumour cell proliferation, microvessel density, and patient prognosis in clear cell renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06376.X

21 January 2018

Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06376.X

21 January 2018

Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06376.X

21 January 2018

Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06376.X

21 January 2018

The von Hippel-Lindau tumor suppressor gene is required for cell cycle exit upon serum withdrawal

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06376.X

21 January 2018

Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06376.X

21 January 2018

The von Hippel-Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06376.X

21 January 2018

Regulation of hypoxia-inducible factor 1alpha expression and function by the mammalian target of rapamycin.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06376.X

21 January 2018

Interleukin 6 induces the expression of vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06376.X

21 January 2018

Fibroblast growth factor 2 activation of stromal cell vascular endothelial growth factor expression and angiogenesis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06376.X

21 January 2018

Enhanced expression of vascular endothelial growth factor in human SaOS-2 osteoblast-like cells and murine osteoblasts induced by insulin-like growth factor I.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06376.X

21 January 2018

Induction of vascular endothelial growth factor by tumor necrosis factor alpha in human glioma cells. Possible roles of SP-1.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06376.X

21 January 2018

Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06376.X

21 January 2018

Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06376.X

21 January 2018

Hypoxia-mediated regulation of gene expression in mammalian cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06376.X

21 January 2018

TSC2 regulates VEGF through mTOR-dependent and -independent pathways

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06376.X

21 January 2018

Identifiers

10.1111/J.1464-410X.2006.06376.X

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/16827904

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/16827904

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46014175&oldid=1531321365"